Impax Asset Management Group PLC Grifols Sa Transaction History

Impax Asset Management Group PLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$14.07 - $17.3 $89.5 Million - $110 Million	-6,359,294 Closed	0 $0
Q2 2021 Aug 05, 2021	SELL	$16.62 - $18.94 $20.6 Million - $23.5 Million	-1,242,378 Reduced 16.34%	6,359,294 $110 Million
Q1 2021 May 14, 2021	BUY	$15.15 - $19.78 $37.9 Million - $49.5 Million	2,500,503 Added 49.02%	7,601,672 $131 Million
Q4 2020 Feb 16, 2021	BUY	$16.86 - $19.67 $29.9 Million - $34.9 Million	1,775,577 Added 53.39%	5,101,169 $94.1 Million
Q3 2020 Nov 12, 2020	BUY	$15.4 - $20.16 $15.4 Million - $20.1 Million	998,120 Added 42.88%	3,325,592 $57.7 Million
Q2 2020 Aug 14, 2020	BUY	$18.24 - $21.45 $5.81 Million - $6.83 Million	318,399 Added 15.85%	2,327,472 $42.5 Million
Q1 2020 May 15, 2020	BUY	$16.28 - $25.63 $20.8 Million - $32.8 Million	1,279,698 Added 175.45%	2,009,073 $40.5 Million
Q4 2019 Feb 13, 2020	BUY	$19.57 - $23.52 $2.22 Million - $2.67 Million	113,495 Added 18.43%	729,375 $17 Million
Q3 2019 Nov 14, 2019	BUY	$19.85 - $22.76 $1.05 Million - $1.2 Million	52,878 Added 9.39%	615,880 $12.3 Million
Q2 2019 Aug 13, 2019	BUY	$17.59 - $21.1 $864,249 - $1.04 Million	49,133 Added 9.56%	563,002 $11.9 Million
Q1 2019 May 13, 2019	BUY	$18.01 - $20.11 $570,556 - $637,084	31,680 Added 6.57%	513,869 $10.3 Million
Q4 2018 Feb 14, 2019	BUY	$17.44 - $21.53 $7.9 Million - $9.76 Million	453,098 Added 1557.52%	482,189 $8.85 Million
Q3 2018 Nov 14, 2018	BUY	$19.97 - $21.96 $580,947 - $638,838	29,091 New	29,091 $622,000

169

145M

166K

103K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.06B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Impax Asset Management Group PLC, based on Form 13F filings with the SEC.

Stay updated on Impax Asset Management Group PLC with notifications on news.